The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients

BRAF and KRAS mutations are well-established biomarkers in anti-EGFR therapy. However, the prognostic significance of these mutations is still being examined. We determined the prognostic value of BRAF and KRAS mutations in Korean colorectal cancer (CRC) patients. | The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
193    3    1    16-05-2021